Integrated PCR amplification and detection processes on a Lab-on-Chip platform: A new advanced solution for molecular diagnostics

Barbara Foglieni, Angela Brisci, Floriana San Biagio, Patrizia Di Pietro, Salvatore Petralia, Sabrina Conoci, Maurizio Ferrari, Laura Cremonesi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Several microdevices have been developed to perform only a single step of a genotyping process, such as PCR or detection by probe hybridization. Here, we describe a Lab-on-Chip (LoC) platform integrating a PCR amplification microreactor with a customable microarray for the detection of sequence variations on human genomic DNA. Methods: Preliminary work was focused on developing the single analytical steps including PCR and labeling strategies of the amplified product by conventional reference systems. The optimized protocols included a 1:4 forward:reverse primer ratio for asymmetric PCR, and Cy5-dCTP multiple incorporation for the generation of a labeled PCR product to be hybridized to complementary probes bound to the chip surface. Results: Final conditions were applied to the fully integrated LoC platform for the detection of the IVSI-110 G>A mutation in the human β-globin (HBB) gene associated with β-thalassemia, used as a model of genetic application, allowing for correct genotyping of 25 samples that were heterozygous, homozygous or wild-type for this mutation. Conclusions: The overall results show that the present platform is very promising for rapid identification of DNA sequence variations in an integrated, cost effective and convenient silicon chip format.

Original languageEnglish
Pages (from-to)329-336
Number of pages8
JournalClinical Chemistry and Laboratory Medicine
Volume48
Issue number3
DOIs
Publication statusPublished - Mar 1 2010

Fingerprint

Lab-on-a-chip
Molecular Pathology
Amplification
Polymerase Chain Reaction
Globins
DNA sequences
Silicon
Microarrays
Labeling
Genes
DNA
Mutation
Thalassemia
Genetic Models
Costs
Costs and Cost Analysis
Cy5-dCTP

Keywords

  • Lab-on-Chip
  • Microarray
  • Microdevice
  • Mutation detection

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Integrated PCR amplification and detection processes on a Lab-on-Chip platform : A new advanced solution for molecular diagnostics. / Foglieni, Barbara; Brisci, Angela; Biagio, Floriana San; Pietro, Patrizia Di; Petralia, Salvatore; Conoci, Sabrina; Ferrari, Maurizio; Cremonesi, Laura.

In: Clinical Chemistry and Laboratory Medicine, Vol. 48, No. 3, 01.03.2010, p. 329-336.

Research output: Contribution to journalArticle

Foglieni, Barbara ; Brisci, Angela ; Biagio, Floriana San ; Pietro, Patrizia Di ; Petralia, Salvatore ; Conoci, Sabrina ; Ferrari, Maurizio ; Cremonesi, Laura. / Integrated PCR amplification and detection processes on a Lab-on-Chip platform : A new advanced solution for molecular diagnostics. In: Clinical Chemistry and Laboratory Medicine. 2010 ; Vol. 48, No. 3. pp. 329-336.
@article{ebabf5bf3447493b9f2d47993024924d,
title = "Integrated PCR amplification and detection processes on a Lab-on-Chip platform: A new advanced solution for molecular diagnostics",
abstract = "Background: Several microdevices have been developed to perform only a single step of a genotyping process, such as PCR or detection by probe hybridization. Here, we describe a Lab-on-Chip (LoC) platform integrating a PCR amplification microreactor with a customable microarray for the detection of sequence variations on human genomic DNA. Methods: Preliminary work was focused on developing the single analytical steps including PCR and labeling strategies of the amplified product by conventional reference systems. The optimized protocols included a 1:4 forward:reverse primer ratio for asymmetric PCR, and Cy5-dCTP multiple incorporation for the generation of a labeled PCR product to be hybridized to complementary probes bound to the chip surface. Results: Final conditions were applied to the fully integrated LoC platform for the detection of the IVSI-110 G>A mutation in the human β-globin (HBB) gene associated with β-thalassemia, used as a model of genetic application, allowing for correct genotyping of 25 samples that were heterozygous, homozygous or wild-type for this mutation. Conclusions: The overall results show that the present platform is very promising for rapid identification of DNA sequence variations in an integrated, cost effective and convenient silicon chip format.",
keywords = "Lab-on-Chip, Microarray, Microdevice, Mutation detection",
author = "Barbara Foglieni and Angela Brisci and Biagio, {Floriana San} and Pietro, {Patrizia Di} and Salvatore Petralia and Sabrina Conoci and Maurizio Ferrari and Laura Cremonesi",
year = "2010",
month = "3",
day = "1",
doi = "10.1515/CCLM.2010.063",
language = "English",
volume = "48",
pages = "329--336",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "3",

}

TY - JOUR

T1 - Integrated PCR amplification and detection processes on a Lab-on-Chip platform

T2 - A new advanced solution for molecular diagnostics

AU - Foglieni, Barbara

AU - Brisci, Angela

AU - Biagio, Floriana San

AU - Pietro, Patrizia Di

AU - Petralia, Salvatore

AU - Conoci, Sabrina

AU - Ferrari, Maurizio

AU - Cremonesi, Laura

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Background: Several microdevices have been developed to perform only a single step of a genotyping process, such as PCR or detection by probe hybridization. Here, we describe a Lab-on-Chip (LoC) platform integrating a PCR amplification microreactor with a customable microarray for the detection of sequence variations on human genomic DNA. Methods: Preliminary work was focused on developing the single analytical steps including PCR and labeling strategies of the amplified product by conventional reference systems. The optimized protocols included a 1:4 forward:reverse primer ratio for asymmetric PCR, and Cy5-dCTP multiple incorporation for the generation of a labeled PCR product to be hybridized to complementary probes bound to the chip surface. Results: Final conditions were applied to the fully integrated LoC platform for the detection of the IVSI-110 G>A mutation in the human β-globin (HBB) gene associated with β-thalassemia, used as a model of genetic application, allowing for correct genotyping of 25 samples that were heterozygous, homozygous or wild-type for this mutation. Conclusions: The overall results show that the present platform is very promising for rapid identification of DNA sequence variations in an integrated, cost effective and convenient silicon chip format.

AB - Background: Several microdevices have been developed to perform only a single step of a genotyping process, such as PCR or detection by probe hybridization. Here, we describe a Lab-on-Chip (LoC) platform integrating a PCR amplification microreactor with a customable microarray for the detection of sequence variations on human genomic DNA. Methods: Preliminary work was focused on developing the single analytical steps including PCR and labeling strategies of the amplified product by conventional reference systems. The optimized protocols included a 1:4 forward:reverse primer ratio for asymmetric PCR, and Cy5-dCTP multiple incorporation for the generation of a labeled PCR product to be hybridized to complementary probes bound to the chip surface. Results: Final conditions were applied to the fully integrated LoC platform for the detection of the IVSI-110 G>A mutation in the human β-globin (HBB) gene associated with β-thalassemia, used as a model of genetic application, allowing for correct genotyping of 25 samples that were heterozygous, homozygous or wild-type for this mutation. Conclusions: The overall results show that the present platform is very promising for rapid identification of DNA sequence variations in an integrated, cost effective and convenient silicon chip format.

KW - Lab-on-Chip

KW - Microarray

KW - Microdevice

KW - Mutation detection

UR - http://www.scopus.com/inward/record.url?scp=77249156977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249156977&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2010.063

DO - 10.1515/CCLM.2010.063

M3 - Article

C2 - 20020819

AN - SCOPUS:77249156977

VL - 48

SP - 329

EP - 336

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 3

ER -